Search
Friday 10 July 2015
  • :
  • :
Latest Update

Pre-Market News Analysis on: Prospect Capital (NASDAQ:PSEC), MFA Financial, (NYSE:MFA), Momenta Pharmaceuticals, (NASDAQ:MNTA), Omnicom Group (NYSE:OMC)

On Thursday, Prospect Capital Corporation (NASDAQ:PSEC)’s shares showed no change to $7.42.

Prospect Capital Corporation (PSEC) declared that Prospect has offered Capstone Logistics, LLC (“Capstone”), an existing portfolio company of Prospect, with an incremental $37.5 million of floating rate secured term debt to support Capstone’s acquisition of Pinnacle Workforce Logistics LLC (“Pinnacle”). Prospect holds Capstone’s entire senior second lien facility, which totals about $100 million.

Headquartered in Atlanta, Capstone services over 50 customers at more than 240 facilities across 45 states. Capstone is an outsourced supply-chain-solutions provider offering freight handling services, supply-chain consulting, and administration of distribution centers. Capstone’s workforce solutions allow distribution center operators to outsource non-core labor-intensive elements of their supply chains. The Jordan Company, L.P. purchased Capstone in August 2014.

Prospect Capital Corporation is a business development company. It specializes in middle market, mature, mezzanine finance, later stage, emerging growth, buyouts, recapitalizations, turnaround, growth capital, development, and subordinated debt tranches of collateralized loan obligations, cash flow term loans, and bridge transactions. It also makes real estate investments particularly in multi-family residential real estate asset class. The fund makes secured debt, senior debt, unitranche debt, first-lien and second lien, private debt, mezzanine debt, and equity investments in private and microcap public businesses.

MFA Financial, Inc. (NYSE:MFA)’s shares gained 0.54% to $7.51.

MFA Financial, Inc. (MFA) declared that its Board of Directors declared a regular quarterly cash dividend of $0.20 per share of common stock for the second quarter of 2015. The dividend will be paid on July 31, 2015, to stockholders of record on June 29, 2015.

MFA Financial, Inc., a real estate investment trust (REIT), invests in residential agency and non-agency mortgage-backed securities (MBS), and residential whole loans in the United States (the U.S.). Its MBS are secured by hybrid mortgages, adjustable-rate mortgages, and 15-year and longer term fixed-rate mortgages, in addition to by mortgages that have interest rates that reset more frequently.

At the end of Thursday’s trade, Momenta Pharmaceuticals, Inc. (NASDAQ:MNTA)‘s shares dipped -5.17% to $21.27.

Momenta Pharmaceuticals, Inc. (MNTA) declared that Sandoz has initiated its U.S. launch of once daily Glatopa(TM) (glatiramer acetate injection), a generic equivalent of daily COPAXONE(R) 20 mg, developed under a partnership agreement between Momenta and Sandoz. Glatopa is the first AP-rated substitutable generic indicated for the treatment of patients with relapsing-forms of multiple sclerosis (RRMS), a chronic disease of the central nervous system characterized by inflammation and neurodegeneration.

Under the terms of its partnership agreement with Sandoz, Momenta will receive a $10.0 million milestone payment upon first commercial sale. Momenta is also eligible to receive up to $120 million in remaining milestone payments upon the achievement of certain U.S. commercial an

Momenta Pharmaceuticals, Inc., a biotechnology company, focuses on developing generic versions of complex drugs, biosimilars, and novel therapeutics for oncology and autoimmune diseases. The company’s complex generics programs comprise Enoxaparin sodium injection, a generic version of Lovenox that is used for the prevention and treatment of deep vein thrombosis, and to support the treatment of acute coronary syndromes; and M356, a generic version of Copaxone, which is a complex drug comprising of a synthetic mixture of polypeptide chains for the treatment of patients with relapsing-remitting multiple sclerosis.

Omnicom Group Inc. (NYSE:OMC), ended its Thursday’s trading session with -0.77% loss, and closed at $69.36.

While the media comments on AutoNation’s 10 millionth car sale and $20 million ad campaign with Zimmerman Advertising in recognition of the benchmark, it’s time to put the microscope to over 15 years of partnership between the nation’s largest auto retailer and Omnicom Group Inc. (OMC)’s retail growth machine. Mutual ambition and commitment to results has meant not only an enduring professional relationship, but the generation of comprising success through a period of transition for the advertising industry and a protracted economic downturn.

Since AutoNation partnered with Zimmerman 15+ years ago, the days of simple TV, radio and print ads have fully evolved into much more. While AutoNation continued to buy up local and regional dealerships around the country, Zimmerman paid close attention to retail trends and expanded to integrate their agency for the changing landscape.

The launch of the largest ad campaign in AutoNation history follows noteworthy milestones for both client and agency. While AutoNation made a bold move towards becoming a national retail chain in 2013 by replacing all localized brand names throughout the country with the company’s corporate moniker, Zimmerman invested and accomplished construction on a new headquarters for their fast-growing team and client roster; moving into the only state-of-the-art advertising hub of its kind in the nation.

Omnicom Group Inc., together with its subsidiaries, operates as an advertising, marketing, and corporate communications services company in the Americas, Europe, the Middle East, Africa, and the Asia pacific. It offers services in advertising, customer relationship management, public relations, and specialty communications areas.

DISCLAIMER:

This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.

All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.

Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.

Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.




Leave a Reply

Your email address will not be published. Required fields are marked *